Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00230555 · ClinicalTrials.gov registry record · Phase 3
The MOM Program at the Children's Hospital of Philadelphia
A Phase 3 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
NCT00230555 is a Phase 3 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 300 participants.
The verdict
NCT00230555, a Phase 3 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of the MOM Program is to promote child development by helping families become more competent in accessing and using available resources. The program focuses are childhood immunizations, Early Intervention services, lead screening, Early Head Start and Head Start enrollment. The hypothsis is that children receiving the intervention will participate in more of the public services and primary healthcare activities which have been shown to be effective in improving their development.
Interventions
- BEHAVIORAL professional support model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2001-07 |
| Est. Completion | 2004-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00230555
The ClinicalTrials.gov registry entry for NCT00230555 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which professional support model is the first listed.
NCT00230555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00230555 about?
NCT00230555 is a clinical study titled "The MOM Program at the Children's Hospital of Philadelphia". The purpose of the MOM Program is to promote child development by helping families become more competent in accessing and using available resources. The program focuses are childhood immunizations, Early Intervention services, lead screening, Early Head Start and Head Start enrollment. The hypothsis...
What is the current status of trial NCT00230555?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2001-07. Estimated completion is 2004-11.
What interventions are being tested in trial NCT00230555?
The interventions under investigation include: professional support model (BEHAVIORAL).
Who is sponsoring clinical trial NCT00230555?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.